TVS Moter rallies over 4%, hits 52- week high on August sale numbers

BSE Code - 532343
Face Value - Rs 1.00
Group - BSE 'B'
Shareholding pattern -(a)Promoters - 57.40%
                                 (b)Institutions - 23.25%
                                 (c)Non-Institutions - 19.35%
One year High-Low -Rs 202.15 - Rs 28.75
     TVS Motor Company has recorded 46% increase in total sales registering 2,27,482 units in the month of August 2014 against 1,55,532 units recorded in the month of August, 2013. The company's total exports grew by 28% with sales increasing from 27,425 units in the month of August 2013 to 35,074 units in August 2014.
     The total two wheeler sales increased by 47% from 1,48,469 units recorded in August 2013 to 2,17,632 units for the month under review. Domestic two wheeler sales registered a growth of 50%, increasing to 1,90,547 units for the month under review from 1,27,095 units in the corresponding month previous year.
     Scooters sales grew by 84% at 67,240 units in August, 2014 from 36,478 units in August, 2013. Motorcycles sales grew by 36% at 83,332 units in August as compared to 61,313 on Y-o-Y basis. Further, three wheeler sales of the company registered an increase of 39%, growing from 7,063 units in August 2013 to 9,820 units in August 2014.
     Current stock price is Rs 201.30, up by 7.90 points from its previous closing of Rs 193.40 on the BSE.

Hero MotoCorp rises on reporting 21.43% rise in August sales

BSE Code - 500182
Face Value - Rs 2.00
Group - BSE 'A'
Shareholding pattern - (a)Promoters - 39.92%
                                  (b)Institutions - 41.96%
                                  (c)Non-Institutions - 18.12%
One year High-Low - Rs 2820.40 - Rs 1879.00
     Hero MotoCorp is the World’s single largest two-wheeler motorcycle company. Honda Motor Company of Japan and the Hero Group entered a joint venture to setup Hero Honda Motors in 1984. Hero Honda Motors changed its name to Hero MotoCorp following the exit of its erstwhile Japanese promoter, Honda, from the company.

   The country’s largest two-wheeler maker Hero MotoCorp has reported 21.43% rise in its total sales at 5,58,609 units in August 2014 as compared to 4,59,996 units sold in the same month last year.

    Moreover, the company will keep up with the growth momentum for the festive season with as many as 10 new launches, including new models, upgrades and refreshes during this period.

     Current price of share is Rs 2801.65 , up by 42.40 points from its previous closing of Rs 2759.25 on the BSE.

Cipla surges on launch of anti-asthma inhaler in Germany, Sweden

BSE Code - 500087
Face Value - Rs 2.00
Group - BSE 'A'
Shareholding pattern - (a)Promoters - 36.80%
                                       (b)Institutions - 35.86%
                                       (c)Non-Institutions - 26.23%
One year High-Low - Rs 575.20 - Rs 366.70
     Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries. Its portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.
     Cipla, a global pharmaceutical company, has launched Serroflo, its Salmeterol/Fluticasone MDI, in Germany and Sweden. With this launch, Cipla opens the door for new, highly efficient treatments in the European healthcare market. Serroflo will substantially improve the affordability of Fixed Combinations in Europe and help manage health costs for respiratory treatment.
     In Germany the new product is distributed under the name ‘Serroflo’, whereas in Sweden the combination is launched as ‘Salmeterol/Fluticasone Cipla’. Serroflo and Salmeterol/Fluticasone Cipla will be available in a pMDI with HFA propellant in two strengths - 120 doses of 25/125 mcg salmeterol/fluticasone and 120 doses of 25/250 mcg salmeterol/fluticasone.
     Current stock price is Rs 557.40, up by 27.70 points from its previous closing of Rs 529.70 on the BSE.

M & M plan to invest Rs 4.000 crore for expansion of Chakan plant

BSE Code - 500520
Face Value - Rs 5.00
Group - BSE 'A'
Shareholding patterns -(a)Promoters - 25.25%
                                   (b)Institutions - 54.77%
                                   (c)Non-Institutions - 14.90%
One year High-Low - Rs 1418 - Rs 749
     In a bid to expand its existing facility at Chakan in Maharashtra, Mahindra & Mahindra (M&M) is planning to invest Rs 4,000 crore over a 7-year period. The fresh infusion would take the company’s total investment in Chakan to Rs 8,000 crore.
     A total of Rs 4,000 crore will be utilised towards infrastructure development, product development and capacity expansion for vehicles to be rolled out from the Chakan plant.
     Earlier, the company had decided to put on hold all investment at its Chakan plant due to VAT refund issues with Maharashtra Government.
     Mahindra & Mahindra (M&M) is the flagship company of the Mahindra Group, a multinational conglomerate based in Mumbai, India. Amongst the various business interests of its parent group, the company is mainly involved in the automobile manufacturing. It is one of the leading auto companies of India.
     Stock is currently trading at Rs 1405.70, down by 1.15 points from its previous closing of Rs 1406.85 on the BSE.

Bharti Airtel gains as arm inks definitive agreement with Essar Telecommunications Kenya

 

  Bharti Airtel is a leading integrated telecommunications company with operations in 20 countries across Asia and Africa. The company ranks amongst the top 5 mobile service providers globally in terms of subscribers.
     Bharti Airtel’s Airtel Networks Kenya has signed a definitive agreement with Essar Telecommunications Kenya which operates under the brand name ‘yuMobile’, to acquire its over 2.7 million subscribers. The company has taken this step pursuant to approval from the Communication Authority (CA) of Kenya. This transaction is subject to approval from Competition Authority of Kenya (CAK) and is likely to be concluded by fourth quarter of 2014.
     Airtel Networks Kenya is a wholly owned subsidiary of Bharti Airtel International Netherlands BV, an arm of Bharti Airtel.
     Stock is currently trading at Rs 376, up by 6.30 points from its previous closing of Rs 369.70 on the BSE.

Wockhardt Ltd rallies on receiving QIDP status for two drugs

BSE Code - 532300
Face Value - Rs 5
Group - BSE'A'
Shareholding Pattern - (a)Promoters - 74.53%
                                   (b)Institutions - 8.51%
                                   (c)Non-Institutions - 16.82%
One year High-Low - Rs 847.95 - Rs 336.60
     Drug maker Wockhardt has received Qualified Infectious Disease Product (QIDP) status from the US health regulator -- US Food and Drug Administration (USFDA) -- for two of its anti-infective drugs WCK 771 and WCK 2349. This is the first instance of an Indian pharmaceutical company receiving QIDP status.
     These drugs will be entering their global Phase-3 clinical trials early next year. QIDP status is granted to drugs which act against pathogens which have a high degree of unmet need in their treatment and are identified by the Centre for Disease Control, USA, a top US government health and safety body.
     WCK 771 is an intravenous (IV) drug while WCK 2349 is a solid oral tablet. Both act against Methicillin-resistant Staphylococcus Aureus (MRSA), which causes a range of diseases from skin infection to severe respiratory infections.
     Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.
     Stock is currently trading at Rs 714.45, up by 23.95 points from its previous closing of Rs 690.50 on the BSE.

Indraprashta Gas soars on entering into SPA to acquire upto 5 crore equity shares of MNGL

BSE Code - 532514
Face Value - Rs 10.00
Group - BSE 'A'
Shareholding Pattern -(a)Promoters - 45.00%
                                  (b)Institutions - 36.65%
                                  (c)Non-Institutions - 18.35%
One year High-Low - Rs 393.75 - Rs 238.85
     Indraprastha Gas has signed Share Purchase Agreement (SPA) to acquire upto 50,000,000 equity shares of Rs 10 each of Maharashtra Natural Gas (MNGL) at a price of Rs 38 per equity share from certain financial investor shareholders of MNGL in such a manner so that upto completion of the proposed transaction the Company's shareholding in MNGL shall not exceed 50% of the issued, subscribed and paid up share capital of MNGL. MNGL is in City Gas Distribution business in Pune in the State of Maharashtra.
     Indraprastha Gas, incorporated in 1998, is engaged in distribution of Compressed Natural Gas (CNG) and Piped Natural Gas (PNG) in Delhi. In 1999 the company took over Delhi City Gas Distribution Project from GAIL (India). IGL laid the network for the distribution of natural gas in the National Capital of Delhi to consumers in the domestic, transport, and commercial sectors.
     Stock is currently trading at Rs 392.15, up by 13.85 points from its previous closing of Rs 378.30 on the BSE.